NASDAQ:NEOG - Neogen Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$63.97 +0.91 (+1.44 %)
(As of 03/20/2019 03:59 AM ET)
Previous Close$63.06
Today's Range$63.81 - $65.09
52-Week Range$52.10 - $97.38
Volume201,219 shs
Average Volume187,964 shs
Market Capitalization$3.33 billion
P/E Ratio52.87
Dividend YieldN/A
Beta1.35
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:NEOG
CUSIP64049110
Phone517-372-9200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$402.25 million
Cash Flow$1.5989 per share
Book Value$10.86 per share

Profitability

Net Income$63.14 million

Miscellaneous

Employees1,546
Market Cap$3.33 billion
Next Earnings Date3/26/2019 (Confirmed)
OptionableOptionable

Neogen (NASDAQ:NEOG) Frequently Asked Questions

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

When did Neogen's stock split? How did Neogen's stock split work?

Shares of Neogen split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were distributed to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How will Neogen's stock buyback program work?

Neogen declared that its board has authorized a share repurchase plan on Wednesday, October 10th 2018, which allows the company to buyback 3,000,000 outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company's board believes its shares are undervalued.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) posted its earnings results on Thursday, December, 20th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.01. The company earned $107.10 million during the quarter, compared to the consensus estimate of $108.52 million. Neogen had a net margin of 15.88% and a return on equity of 11.45%. Neogen's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.33 earnings per share. View Neogen's Earnings History.

When is Neogen's next earnings date?

Neogen is scheduled to release their next quarterly earnings announcement on Tuesday, March 26th 2019. View Earnings Estimates for Neogen.

How can I listen to Neogen's earnings call?

Neogen will be holding an earnings conference call on Tuesday, March 26th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

What price target have analysts set for NEOG?

3 equities research analysts have issued 1-year price objectives for Neogen's shares. Their predictions range from $62.76 to $65.00. On average, they anticipate Neogen's stock price to reach $63.88 in the next twelve months. This suggests that the stock has a possible downside of 0.1%. View Analyst Price Targets for Neogen.

What is the consensus analysts' recommendation for Neogen?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Neogen.

Has Neogen been receiving favorable news coverage?

Media stories about NEOG stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Neogen earned a daily sentiment score of -2.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.

Who are some of Neogen's key competitors?

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include JPMorgan Chase & Co. (JPM), Nike (NKE), Boeing (BA), Pfizer (PFE), AT&T (T), Celgene (CELG), GW Pharmaceuticals PLC- (GWPH), Visa (V), Edwards Lifesciences (EW) and NVIDIA (NVDA).

Who are Neogen's key executives?

Neogen's management team includes the folowing people:
  • Mr. James L. Herbert, Exec. Chairman (Age 79)
  • Mr. John Edward Adent, CEO & Pres (Age 51)
  • Mr. Steven J. Quinlan, VP, CFO & Sec. (Age 57)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 54)
  • Mr. Rod Poland, Director of Corp. Communications

Who are Neogen's major shareholders?

Neogen's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.25%), Conestoga Capital Advisors LLC (2.92%), Riverbridge Partners LLC (1.74%), Norges Bank (1.66%), New York State Common Retirement Fund (1.65%) and King Luther Capital Management Corp (1.56%). Company insiders that own Neogen stock include Edward Bradley, G Bruce Papesh, Jack C Parnell, James L Herbert, James P Tobin, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Institutional Ownership Trends for Neogen.

Which institutional investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including King Luther Capital Management Corp, PNC Financial Services Group Inc., Riverbridge Partners LLC, Barclays PLC, BlackRock Inc., Principal Financial Group Inc., Two Sigma Advisers LP and MetLife Investment Advisors LLC. Company insiders that have sold Neogen company stock in the last year include G Bruce Papesh, Jack C Parnell, James L Herbert, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Insider Buying and Selling for Neogen.

Which institutional investors are buying Neogen stock?

NEOG stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, WINTON GROUP Ltd, Ardevora Asset Management LLP, Eagle Asset Management Inc., Ranger Investment Management L.P., Conestoga Capital Advisors LLC, Geode Capital Management LLC and Geode Capital Management LLC. Company insiders that have bought Neogen stock in the last two years include James P Tobin and John Edward Adent. View Insider Buying and Selling for Neogen.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $63.97.

How big of a company is Neogen?

Neogen has a market capitalization of $3.33 billion and generates $402.25 million in revenue each year. The company earns $63.14 million in net income (profit) each year or $1.21 on an earnings per share basis. Neogen employs 1,546 workers across the globe.

What is Neogen's official website?

The official website for Neogen is http://www.neogen.com.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]


MarketBeat Community Rating for Neogen (NASDAQ NEOG)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  349 (Vote Underperform)
Total Votes:  605
MarketBeat's community ratings are surveys of what our community members think about Neogen and other stocks. Vote "Outperform" if you believe NEOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEOG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Featured Article: 12b-1 Fees

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel